"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

"Due to the timing of diagnosis during this critical period of physical, intellectual, and psychosocial development, the higher rate of colectomy, and their longer lifespan without a colon, it is ...

Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...

Greater access to innovative treatments could be linked to a drop in patients requiring surgery for a type of inflammatory bowel disease, a 20-year study suggests. The number of patients using ...

p #60; 0.001. Data from [74]. Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA ...

NEW YORK A new study led by Mayo Clinic researchers found that ulcerative colitis patients had a 41% reduction in colectomy when treated with infliximab for one year, according to a study published in ...

An AI workflow accurately grouped ulcerative colitis‑LGD patients by cancer risk, flagging about half as low‑risk with a ~99 % chance of staying cancer‑free for two years. The AI workflow revealed ...

A major operation that is often performed on women with severe inflammation of the colon appears to reduce their fertility, researchers report this month in the journal Gastroenterology. The condition ...

Crohn’s and UC affect the GI tract differently. Crohn’s impacts the whole tract, while UC is limited to the colon. Learn the ...

People with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population. Low-grade dysplasia (LGD)—abnormal ...